Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy for Recurrent Clostridium difficile-associated Diarrhea
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
CDAD is the major known cause of antibiotic-induced diarrhea and colitis, and the disease is thought to result from persistent disruption of commensal gut microbiota.Bacteriotherapy by way of fecal transplantation can be used to treat recurrent CDAD and is thought to re-establish the normal colonic microflora.However, limitations of conventional microbiologic techniques have until recently precluded testing of this idea.In this study we used T-RFLP and 16S rRNA gene sequencing approaches to characterize the bacterial composition of the colonic microflora in a patient suffering from recurrent CDAD, before and after treatment by fecal transplantation from a healthy donor.While the patient's residual colonic microbiota, prior to therapy, was deficient in members of the bacterial divisions-Firmicutes and Bacteriodetes, transplantation had a dramatic impact on the composition of the patient's gut microbiota.By 14 days post transplantation, the fecal bacterial composition of the recipient was highly similar to the donor and was dominated by Bacteroides spp.strains and an uncharacterized butyrate producing bacterium.The change in bacterial composition was accompanied by resolution of the patient's symptoms.The striking similarity of the recipient's and donor's intestinal microbiota following bacteriotherapy suggests that the donor's bacteria quickly occupied their requisite niches, resulting in restoration of both the structure and function of the microbial communities present.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple studies have demonstrated remarkable effectiveness of FMT in cases of recurrent and refractory CDI, which may be attributed to sustained restoration of the normal microbiota after FMT.22,23”
From Fecal microbiota transplantation: Review and update (2019) · cites this paper as [22]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Indeed, studies have demonstrated that patients suffering from recurrent CDI are deficient in phyla of bacteria normally dominant in the colon6,45 (Figure 1).”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [6]
In the citing paper
“Moreover, the restoration of more typical microbial communities, which come to resemble those of the donor post-transplant, persists in a durable fashion after FMT.6, 7”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [6]
In the citing paper
“FMT appears to result in durable engraftment of new species from donor as well as augmentation of species present at only very low levels prior to FMT6.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Muyzer, G., de Waal, E. C., & Uitterlinden, A. G. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.3.695-700.1993 · Cited by 11,429
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 1×
“Many Firmicutes produce butyrate and are postulated to be involved in obesity in humans and murine models.(32,33) Short chain length fatty acids (SCFAs), especially butyrate, have also been shown to play a critical role in maintaining integrity of the colonic epithelium and regulation of the mucosal immune responses.”
BackgroundDiversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 1×
“These bacteria are well-known dominant members of human fecal microbiota,(16) and these phyla are thought to play major ecologic roles in establishment and maintenance of gut homeostasis.(30) A lack of Bacteroides sp.”
BackgroundDevelopment of the Human Infant Intestinal Microbiota
Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A., & Brown, P. O. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050177 · Cited by 2,877
Edwards, U., Rogall, T., Blöcker, H., Emde, M., & Böttger, E. C. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.19.7843 · Cited by 2,724 · cited 1×
“primers Bact-8F (5’-AGAGTTTGATCCTGGCTCAG-3’) [25] 5′ end-labeled with 6-”
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361
Clostridium difficile— More Difficult Than Ever
Kelly, C. P., & LaMont, J. T. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707500 · Cited by 1,313 · cited 4×
“Unfortunately, the same problem is encountered by others treating this disease.(1) In the studies reported here, we used a molecular approach to gain a better understanding of the bacterial composition of the GI tract in a CDAD patient.”
BackgroundInfluentialDecreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/525047 · Cited by 1,010 · cited 2×
“However, the composition and species richness of intestinal tract microbiota in individuals with CDAD and recurrent CDAD were found to be markedly different from controls.(14) The reestablishment of the normal composition of the intestinal flora has long been hypothesized to be a curative approach for the recurrent CD…”
Background
Cited by
Items 501–600 of 645
Current Approaches to Treat and Prevent Recurrence of Clostridioides difficile
Ressler, A. M., Rao, K., & Young, V. B. (2025) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2025.02.005 · Cited by 5
Fecal transplantation: re-discovering the value of stool
Davidovics, Z. H., & Hyams, J. S. (2013) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328363ed66 · Cited by 5
“In theory, infusing feces from a healthy person into the intestine of an ill patient changes their bacterial composition and restores the intestinal environment to a healthier state [16].”
BackgroundPrecision Medicine and Challenges in Research and Clinical Implementation
Haga, S. B. (2017) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-803506-1.00021-8 · Cited by 6
Human Skin Bacterial Community Response to Probiotic (Lactobacillus reuteri DSM 17938) Introduction
Frèrejacques, M., Rousselle, C., Gauthier, L., Cottet-Emard, S., Derobert, L., Roynette, A., Lerch, T. Z., & Changey, F. (2020) · Microorganisms · doi:10.3390/microorganisms8081223 · Cited by 5
“Studies dealing with the effect of probiotics on the structure of indigenous microbial communities from different human microbiota have often yielded contradictory results, with no effect [15], short-term effects [16], or significant long-term effects [17].”
BackgroundPediatric Fecal Microbiota Transplantation in Recurrent Clostridioides Difficile
Parnell, J. M., Nicholson, M. R., Kellermayer, R., & Kahn, S. A. (2021) · Pediatric Annals · doi:10.3928/19382359-20211111-01 · Cited by 5
Gholam-Mostafaei, F. S., Azimirad, M., Naseri, K., Nabavi-Rad, A., Aghdaei, H. A., Shahrokh, S., Daryani, N. E., Yadegar, A., & Zali, M. R. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1147945 · Cited by 7
“However, this finding is in contrast with the results of previous studies in which the abundance of phylum Firmicutes increased after bacteriotherapy or FMT in C. difficile-associated disease (CDAD) (Khoruts et al., 2010), and rCDI (Weingarden et al., 2014), respectively.”
BackgroundInfluentialFecal microbiome change in patients with ulcerative colitis after fecal microbiota transplantation
Tikunov, A. Y., Morozov, V. V., Shvalov, А. N., Bardasheva, A. V., Shrainer, E., Maksimova, O. A., Волошина, И. О., Morozova, V. V., Vlassov, V. V., & Викторовна, Т. Н. (2020) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj20.610 · Cited by 5
Clostridium difficile in der Viszeralchirurgie
Herzog, T., Deleites, C., Belyaev, O., Chromik, A. M., & Uhl, W. H. (2014) · Der Chirurg · doi:10.1007/s00104-014-2905-9 · Cited by 5
“Der wichtigste Risikofaktor für das Auftreten einer CDI ist eine vorausgegangene Antibiotikaexposition, da diese die physiologische Darmflora zerstört und die CDI überhaupt erst ermöglicht [17].”
BackgroundDoes the change on gastrointestinal tract microbiome affects host?
Beirão, E. M., Padovan, A. C. B., Furtado, J. J. D., Colombo, A. L., & Medeiros, E. A. (2014) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2014.04.002 · Cited by 9
“Transfer of resistance genes may occur through horizontal gene transfer (HGT) from commensal bacteria to opportunistic pathogens, as previously described CTX-M 1 4;1 8(6):660–663”
BackgroundMicrobial primary production and phototrophy
Kirchman, D. L. (2011) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199586936.003.0004 · Cited by 9
The challenges and opportunities in the expanding horizons of microbiota transplant therapies
Khoruts, A. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2559032 · Cited by 5
“The enhanced level of resolution should be helpful in tracking the dynamics of functional trait acquisition by specific bacterial hosts encoded by phages and plasmids in the context of FMT.”
Self-citationMa, C., Zou, Z., Zhao, W., Rao, Y., Liu, B., Sun, M., & Chen, D. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108381 · Cited by 5
Shapovalov, V., Шаповалова, В., Осинцева, А., & Шаповалов, В. В. (2026) · Drugs and Drug Candidates · doi:10.3390/ddc5030037 · Cited by 7
“Clinical trial data demonstrated their safety and efficacy, including a substantial reduction in recurrence rates [41].”
Clostridium difficileinfection: New insights into therapeutic options
Kachrimanidou, M., Sarmourli, T., Skoura, L., Metallidis, S., & Malisiovas, N. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1027171 · Cited by 6
“According to studies comparing microbiota of CDI patients before and after FMT, a significant domination of Bacteroides and decrease in Proteobacteria occurred, resembling the microbiome of healthy population (Khoruts et al., 2010).”
ResultHuman Microbiome: Implications on Health and Disease
Hira, P., Sood, U., Gupta, V., Nayyar, N., Mahato, N. K., Singh, Y. P., Lal, R., & Shakarad, M. (2017) · Springer eBooks · doi:10.1007/978-981-10-4298-0_8 · Cited by 5
Bang, M.-S., Jeong, H., Lee, Y.-J., Lee, S., Lee, G. S., Kim, S., Lee, H.-H., Shin, J., & Oh, C. (2020) · Microbiology Resource Announcements · doi:10.1128/mra.01341-19 · Cited by 4
MNEMONIC: MetageNomic Experiment Mining to create an OTU Network of Inhabitant Correlations
Perz, A., Giles, C. B., Brown, C. A., Porter, H. L., Roopnarinesingh, X., & Wren, J. D. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2623-x · Cited by 5
“Further, obesity, metabolic syndrome, and type II diabetes [7, 11, 20 – 22], colitis [23, 24], colorectal cancer [25] have all been shown to be associated with changes in microbiome.”
BackgroundMicrobial growth, biomass production, and controls
Kirchman, D. L. (2011) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199586936.003.0006 · Cited by 5
Anti-Germinants as a New Strategy to Prevent Clostridium Difficile Infections
Howerton, A. (2012) · PubMed · doi:10.34917/4332723 · Cited by 4
“Stool samples from donors closely associated with the patient are obtained, diluted with saline, homogenized with a blender and filtered before being instilled into the recipient via enema or nasogastric tube (106-108).”
BackgroundMethodSadowsky, M. J., & Whitman, R. L. (2014) · ASM Press eBooks · doi:10.1128/9781555816865.ch13 · Cited by 4
Self-citationFecal Microbiota Transplantation: An Interview with Alexander Khoruts
Lebeau, S., & Khoruts, A. (2014) · Global Advances in Health and Medicine · doi:10.7453/gahmj.2014.020 · Cited by 4
Self-citationThe Gut Microbiota: Ecology and Function
Willing, B. P., & Jansson, J. K. (2014) · ASM Press eBooks · doi:10.1128/9781555816865.ch3 · Cited by 4
Self-citationThe Price we Pay for Overdose of Antibiotics: Is there any Alternative?
Gupta, P. (2018) · COJ Technical & Scientific Research · doi:10.31031/cojts.2018.01.000509 · Cited by 4
“The mechanism of action of fecal microbiota transplant works by restoring the imbalance [2,8,9].”
BackgroundDevelopment of an In Vitro Fermentation Model to Culture the Human Distal Gut Microbiota
McDonald, J. A. K. (2013) · The Atrium (University of Guelph) · Cited by 8
Clostridioides difficile Infection
Statler, V. A., & Bryant, K. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00047-9 · Cited by 3
Faecal microbiota transplant – prospects and safety
Bartnicka, A., Szachta, P., & Gałęcka, M. (2016) · Pomeranian Journal of Life Sciences · doi:10.21164/pomjlifesci.98 · Cited by 4
Penteado, J. O., Salgado, R. G. F., & Barlem, E. (2017) · VITTALLE - Revista de Ciências da Saúde · doi:10.14295/vittalle.v29i1.6173 · Cited by 6
“Tem se buscado encontrar alternativas para o tratamento da obesidade assim como o transplante da microbiota fecal (TMF), também denominado bacterioterapia fecal, no qual é transplantado comunidades bacterianas fecais de um indivíduo saudável para um indivíduo com a microbiota alterada (12).”
BackgroundGut microbiome: Current development, challenges, and perspectives
Purkait, D., Hameed, S., & Fatima, Z. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820528-0.00016-8 · Cited by 3
The Gut Microbiota and Inflammatory Bowel Disease
Conrad, M. A., Wu, G. D., & Kelsen, J. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-14744-9_4 · Cited by 3
Clostridium difficile infection and gut microbiota
Zalig, S., & Rupnik, M. (2014) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2014.05.005 · Cited by 3
Roundoc Rx: The Human Microbiome—Humans as Super-Organisms
ROUNTREE, R. L. (2011) · Alternative and Complementary Therapies · doi:10.1089/act.2011.17206 · Cited by 4
“17,18 These studies show that it is possible to take an extract of fecal material from a healthy person, process it minimally, and then put the organisms into the GI tract of another person (by nasogastric tube, colonoscopy, or enema) and produce a significant and long-lasting alteration of new…”
Merritt, J., & Kuehn, S. (2016) · eLife · doi:10.7554/elife.18753 · Cited by 4
Kirchman, D. L., & Shade, A. L. (2011) · Oxford University Press eBooks · doi:10.1093/9780197831632.003.0008 · Cited by 3
FMT in Clostridium difficile and Other Potential Uses
Fine, S., & Kelly, C. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00034-3 · Cited by 3
Role of Gut Microbiome in the Modulation of Environmental Toxicants and Therapeutic Agents
Hossain, A., Menezes, G. A., Al, M., & Ashankyty, I. (2016) · CRC Press eBooks · doi:10.1201/9781315371443-25 · Cited by 6
Clostridium difficile : What the surgeon needs to know
Hrebinko, K. A., & Zuckerbraun, B. S. (2017) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2017.09.006 · Cited by 3
Metagenomics of Antimicrobial Resistance in Gut Microbiome
Imchen, M., & Kumavath, R. (2018) · InTech eBooks · doi:10.5772/intechopen.76214 · Cited by 3
Li, Y., Yang, Y., Yang, N., Wu, Q., Yang, J., Guo, J., & Zhang, H. (2024) · Frontiers in Microbiomes · doi:10.3389/frmbi.2024.1409967 · Cited by 3
The past 10 years of gastroenterology and hepatology—reflections and predictions
Friedman, S. L., Quigley, E. M. M., Sharkey, K. A., Sung, J. J. �., & Whitcomb, D. C. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.167 · Cited by 3
Shin, Y. J., & Lee, B. J. (2017) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2017.69.4.203 · Cited by 2
“The Korean Journal of Gastroenterology Bacteroidetes가 감소되어 있었으나, FMT를 시행한 후 환자 들의 장내 세균총이 공여자와 비슷해지고, 이와 함께 증상의 호전이 관찰되어 FMT를 통한 장내 세균 분포의 조절이 가능 함을 보여주고 있다.(8) 본고에 발표된 Bang 등(9)의 연구는 9명의 환자에게 FMT를 시행하여 치료 효과를 보여주었다.”
Future-Generation Sequencing and Clinical Microbiology
Kirkup, B. C., Mahlen, S. D., & Kallstrom, G. (2013) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2013.03.011 · Cited by 2
Fecal Bacteriotherapy for Clostridium difficile Infections — Its Time Has Come
Avery, L., & Hasan, M. S. (2013) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2013.07.002 · Cited by 2
Pediatric Fecal Microbiota Transplantation
Mir, S. A. V., Kellermayer, R., & Gulati, A. (2014) · Current Pediatrics Reports · doi:10.1007/s40124-014-0049-5 · Cited by 2
The Human Microbiota and Pathogen Interactions
Walker, A. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397169-2.00019-6 · Cited by 3
Elements, biochemicals, and structures of microbes
Kirchman, D. L. (2011) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199586936.003.0002 · Cited by 6
The Gut Microbiota, Probiotics and Infectious Disease
Gahan, C. G. M., O’Sullivan, G. C., & Collins, J. K. (2011) · Springer eBooks · doi:10.1007/978-94-007-0386-5_5 · Cited by 2
“Khoruts et al. ( 2009) recently used a 16s DNA sequencing approach to demonstrate that the microbiota of an elderly patient with C. difficile infection was disrupted in components of the Firmicutes and Bacteroides groups.”
MethodThe Role of Integrated Omics in Elucidating the Gut Microbiota Health Potentials
Aw, W., & Fukuda, S. (2015) · Microbiology monographs · doi:10.1007/978-3-319-23213-3_4 · Cited by 2
Paleomicrobiology: a Snapshot of Ancient Microbes and Approaches to Forensic Microbiology
Rivera-Pérez, J. I., Santiago-Rodríguez, T. M., & Toranzos, G. A. (2018) · ASM Press eBooks · doi:10.1128/9781555818852.ch4 · Cited by 2
Hansen, T. C. (2010) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · doi:10.2172/975377 · Cited by 2
Molecular characterization of the penile microbiome of Dorper rams (Ovis aries)
Courchay, A. M. M. (2017) · SUNScholar (Stellenbosch University) · Cited by 5
Fecal microbiota transplantation in allergic diseases
Önata, E. T., & Özdemır, Ö. (2025) · World Journal of Methodology · doi:10.5662/wjm.v15.i2.101430 · Cited by 2
Chen, K., Jin, S., Nie, Y., He, N., Chen, H., Yuan, J., Li, X., & Liong, M.-T. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1727191 · Cited by 2
Dynamics of Microeukaryotes and Archaea in the Mammalian Gut Microbiome
Dollive, S. (2013) · Scholarly Commons (University of Pennsylvania) · Cited by 1
Prebiotics, Probiotics, Synbiotics, and Phage Therapy
ROSENBERG, E. B., & Zilber‐Rosenberg, I. (2013) · Springer eBooks · doi:10.1007/978-3-319-04241-1_10 · Cited by 2
Fecal microbiota transplantation for Clostridium difficile infection: A surgeon׳s perspective
Borody, T. J., & Finlayson, S. (2014) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2014.05.013 · Cited by 1
Manipulation of the Host-Cell Pathways by Bacterial Enteropathogens
Schiffrin, E. J., Marteau, P. R., & Brassart, D. (2014) · CRC Press eBooks · doi:10.1201/b16442-7 · Cited by 1
Fäkale Mikrobiotatransplantation (FMT): Gesicherte Therapieindikationen und Zukunftsperspektiven
Lübbert, C. (2016) · Der Diabetologe · doi:10.1007/s11428-016-0125-2 · Cited by 1
“Innerhalb der ersten beiden Wochen nach der Stuhlübertragung entwickelt sich bei den Empfängern, die vorher eine große Fülle an Proteobacteria, insbesondere Vertretern der Ordnung Enterobacteriales, aufwiesen, eine hochdiverse protektive Spenderflora mit Prädominanz natürlicher Bacteroides-Spezies ([12]; .”
BackgroundTaur, Y. (2016) · Springer eBooks · doi:10.1007/978-3-319-28797-3_51 · Cited by 3
Methods and Models in Exploring Pancreatic Functions
Malla, R. R., Kumari, S., Amajala, K. C., Deepak, K. G. K., Gugalavath, S., & Rokkam, P. (2019) · Springer eBooks · doi:10.1007/978-981-32-9393-9_15 · Cited by 1
Cypers, H., Bridges, S. L., & Elewaut, D. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-79026-8_16 · Cited by 1
den Abbeele, P. V., Verstraete, W., Aidy, S. E., Geirnaert, A., & de Wiele, T. V. (2014) · Apple Academic Press eBooks · doi:10.1201/b17254-17 · Cited by 1
de Vos, W. M. (2014) · Apple Academic Press eBooks · doi:10.1201/b17254-20 · Cited by 1
Precision medicine: Overview and challenges to clinical implementation
Haga, S. B. (2023) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-323-88534-8.00020-1 · Cited by 2
Kelsen, J. R., & Wu, G. D. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5061-0_4 · Cited by 1
Recurrent Clostridium difficile infection: The scope of the problem and management decisions
Sageer, M., & Barto, A. (2014) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2014.05.012 · Cited by 2
Fecal Matter Implantation as a Way to Fight Diarrhea-Causing Microorganisms
Villa, T. G., Feijoo-Siota, L., Rama, J. L. R., Sánchez-Pérez, Á., & de Miguel, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-28368-5_13 · Cited by 2
Genomes and metagenomes of microbes and viruses
Kirchman, D. L. (2011) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199586936.003.0010 · Cited by 1
Systematic Review of Current Treatment and Prevention Strategies for Clostridium difficile
Parmar, N. V., & Glauser, J. M. (2019) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-019-00186-1 · Cited by 2
System Biology Approaches for Nutrition Research
Díaz, F. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.22916-8 · Cited by 1
Microbiomes in Medicine and Agriculture
ROSENBERG, E. B. (2021) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-030-65317-0_10 · Cited by 2
Kirchman, D. L. (2011) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199586936.003.0007 · Cited by 1
Kirchman, D. L. (2011) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199586936.003.0001 · Cited by 1
Probiotics and Gut Health: A Prophylactic to Disease
Welsher, A. (2017) · Food Science & Nutrition Technology · doi:10.23880/fsnt-16000135 · Cited by 1
Tran, V., Phan, J., Nulsen, B., Huang, L., Kaneshiro, M., Weiss, G. A., Ho, W. W., Sack, J. L., Ha, C. Y., Uslan, D. Z., et al. (2018) · ACG Case Reports Journal · doi:10.14309/02075970-201805120-00013 · Cited by 1
Clostridium difficile : new challenges for an old foe
Tillotson, G., & Weiss, K. (2013) · doi:10.2217/ebo.13.271 · Cited by 1
The microbiota as target for therapeutic intervention in pediatric intestinal diseases
Vecchio, A. L., & Guarino, A. (2016) · Wiley eBooks · doi:10.1002/9781118982907.ch31 · Cited by 1
Zeeuwen, P. L. J. M., & Schalkwijk, J. (2016) · Wiley eBooks · doi:10.1002/9781118982907.ch5 · Cited by 1
Gut Microbiota in Health and Disease - An Overview
Shrihari, T. G. (2018) · Gastroenterology Medicine & Research · doi:10.31031/gmr.2018.02.000531 · Cited by 1
“The most common complication followed by administration of antibiotics is the pathological overgrowth of Clostridium difficile and is related to antibioticassociated diarrhea [18].”
BackgroundClostridium difficile Infections and their Treatment
Mattila, E. J. (2013) · Helda - University of Helsinki Institutional Repository
La microbiota intestinal en el desarrollo del sistema inmune del recién nacido
Hernández, D. L. R., Cabezas, E. J. G., & Castañeda, N. S. (2014) · Revista cubana de pediatría · Cited by 19
Beedles, M. (2015) · CommonKnowledge Research Repository (Pacific University Oregon)
von Schillde, M., & Haller, D. (2012) · Pharmazie in unserer Zeit · doi:10.1002/pauz.201100464
Intérêt et technique de la transplantation fécale
Fumery, M., Corcos, O., Kapel, N., Stéfanescu, C., Thomas, M., & Joly, F. (2013) · Journal des Anti-infectieux · doi:10.1016/j.antinf.2013.10.002
Gut microbiota: so much to explore!
Blanco, J. R., & Oteo, J. A. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.814837 · Cited by 1
Towards accessing the proteolytic potential of the gut microbiota
Morris, L. S. (2014) · ORCA Online Research @Cardiff (Cardiff University)
Current advances related to Clostridium difficile infection
Jang, B.-I., & Kim, Y. (2015) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.155545
Identifying Host-Microbiome Interactions in Genomic Data
Lynch, J. K. (2015) · University of Minnesota Digital Conservancy (University of Minnesota)
Metagenomic systems biology: frameworks for modeling and characterizing the gut microbiome
Greenblum, S. I. (2014) · ResearchWorks at the University of Washington (University of Washington)
Hem, E. (2010) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.10.0841
Clostridium difficile Linked to Disrupted Gut Microbiota
Young, V. B., & Aronoff, D. M. (2012) · Microbe Magazine · doi:10.1128/microbe.7.268.1
Correlation Between Gut Microbiota and Depression
Naseribafrouei, A. (2013) · NVA (Nasjonalt vitenarkiv) · Cited by 2
Kirchman, D. L. (2011) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199586936.003.0014
Clostridium difficile Infection
Stewart, D. B. (2016) · Springer eBooks · doi:10.1007/978-3-319-25970-3_53
Adair, B., Bujnevicie, H., Morissette, J., Thomas, K., & Whitney, N. (2015)
Schroeter, K. (2014) · The Atrium (University of Guelph) · Cited by 2
Piatti, G., Mannini, A., & Schito, A. M. (2016) · Journal of Probiotics & Health · doi:10.4172/2329-8901.1000158
McQuade, E. T. R. (2015) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/bz63-vs75
Fecal microbiota transplantation in recurrent C. difficile infection
Granitto, M. H., & Norton, C. (2015) · Nursing Critical Care · doi:10.1097/01.ccn.0000475515.42505.6e · Cited by 1
The microbiome and Clostridium difficile infection
Chiu, C. Y., & Pillai, D. R. (2013) · doi:10.2217/ebo.13.324
Metadata
- Authors
- Khoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J.
- Affiliations
- University of Minnesota (US)
- Swedish University of Agricultural Sciences (SE)
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Khoruts, Alexander
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2010-05
- Volume
- 44
- Issue
- 5
- Pages
- 354-360
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W2095040140
- Cited by
- 649
- References
- 37
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 22 · 2023: 14 · 2022: 13 · 2021: 26 · 2020: 29 · 2019: 41 · 2018: 49 · 2017: 49 · 2016: 53 · 2015: 49 · 2014: 69 · 2013: 88 · 2012: 47
- FWCI
- 44.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Clostridium difficile-associated diarrhea, fecal microbiota transplantation, gut microbiota composition, colonic microbiota, Firmicutes, Bacteroidetes, Bacteroides, butyrate-producing bacteria, antibiotic-associated diarrhea
- MeSH terms
- Enterocolitis, Pseudomembranous, Feces, Female, Follow-Up Studies, Humans, Middle Aged, Polymorphism, Restriction Fragment Length, RNA, Ribosomal, 16S, Clostridioides difficile, Sequence Analysis, RNA, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.